Published in Nucleic Acids Res on October 12, 2016
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy. Genes Dev (2017) 0.81
Structural Characteristics of Simple RNA Repeats Associated with Disease and their Deleterious Protein Interactions. Front Cell Neurosci (2017) 0.75
Myotonic dystrophy: approach to therapy. Curr Opin Genet Dev (2017) 0.75
Autoregulation of MBNL1 function by exon 1 exclusion from MBNL1 transcript. Nucleic Acids Res (2016) 0.75
HITS-CLIP yields genome-wide insights into brain alternative RNA processing. Nature (2008) 14.17
Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell (1992) 12.74
Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. Science (1992) 9.32
An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science (1992) 8.20
Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science (2001) 7.34
Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science (1998) 6.67
A muscleblind knockout model for myotonic dystrophy. Science (2003) 5.93
Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science (2000) 5.85
Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum Mol Genet (2006) 4.35
Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells. Hum Mol Genet (2002) 3.34
Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. Hum Mol Genet (2001) 3.27
Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Hum Mol Genet (2004) 3.21
Transcriptome-wide regulation of pre-mRNA splicing and mRNA localization by muscleblind proteins. Cell (2012) 3.20
Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy. Proc Natl Acad Sci U S A (2006) 3.09
Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy. Nat Struct Mol Biol (2010) 3.07
Muscleblind-like 1 interacts with RNA hairpins in splicing target and pathogenic RNAs. Nucleic Acids Res (2007) 2.95
MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1. J Biol Chem (2004) 2.52
RNA structure of trinucleotide repeats associated with human neurological diseases. Nucleic Acids Res (2003) 2.34
Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy. J Cell Sci (2005) 2.31
CUG repeats present in myotonin kinase RNA form metastable "slippery" hairpins. J Biol Chem (1997) 2.17
The Muscleblind family of proteins: an emerging class of regulators of developmentally programmed alternative splicing. Differentiation (2006) 2.16
Structural insights into RNA recognition by the alternative-splicing regulator muscleblind-like MBNL1. Nat Struct Mol Biol (2008) 2.00
In vivo co-localisation of MBNL protein with DMPK expanded-repeat transcripts. Nucleic Acids Res (2001) 1.97
Muscleblind-like 2-mediated alternative splicing in the developing brain and dysregulation in myotonic dystrophy. Neuron (2012) 1.78
Misregulation of miR-1 processing is associated with heart defects in myotonic dystrophy. Nat Struct Mol Biol (2011) 1.73
RNA Bind-n-Seq: quantitative assessment of the sequence and structural binding specificity of RNA binding proteins. Mol Cell (2014) 1.68
Developmental expression of mouse muscleblind genes Mbnl1, Mbnl2 and Mbnl3. Gene Expr Patterns (2003) 1.49
Molecular mechanisms responsible for aberrant splicing of SERCA1 in myotonic dystrophy type 1. Hum Mol Genet (2007) 1.43
MBNL1 binds GC motifs embedded in pyrimidines to regulate alternative splicing. Nucleic Acids Res (2010) 1.43
RNA mis-splicing in disease. Nat Rev Genet (2015) 1.41
CUGBP1 and MBNL1 preferentially bind to 3' UTRs and facilitate mRNA decay. Sci Rep (2012) 1.35
Structural diversity of triplet repeat RNAs. J Biol Chem (2010) 1.29
easyFRAP: an interactive, easy-to-use tool for qualitative and quantitative analysis of FRAP data. Bioinformatics (2012) 1.25
Muscleblind-like 1 (Mbnl1) promotes insulin receptor exon 11 inclusion via binding to a downstream evolutionarily conserved intronic enhancer. J Biol Chem (2010) 1.23
Splicing biomarkers of disease severity in myotonic dystrophy. Ann Neurol (2013) 1.22
Loss of MBNL leads to disruption of developmentally regulated alternative polyadenylation in RNA-mediated disease. Mol Cell (2014) 1.21
Identification of MBNL1 and MBNL3 domains required for splicing activation and repression. Nucleic Acids Res (2010) 1.20
Compound loss of muscleblind-like function in myotonic dystrophy. EMBO Mol Med (2013) 1.19
Defining early steps in mRNA transport: mutant mRNA in myotonic dystrophy type I is blocked at entry into SC-35 domains. J Cell Biol (2007) 1.16
Endothelial, epithelial, and fibroblast cells exhibit specific splicing programs independently of their tissue of origin. Genome Res (2013) 1.06
Conserved developmental alternative splicing of muscleblind-like (MBNL) transcripts regulates MBNL localization and activity. RNA Biol (2010) 1.03
Solution structure of the RNA binding domain in the human muscleblind-like protein 2. Protein Sci (2009) 1.01
MBNL proteins and their target RNAs, interaction and splicing regulation. Nucleic Acids Res (2014) 1.00
Antagonistic regulation of mRNA expression and splicing by CELF and MBNL proteins. Genome Res (2015) 1.00
Two high-throughput screening assays for aberrant RNA-protein interactions in myotonic dystrophy type 1. Anal Bioanal Chem (2012) 0.99
RNA splicing is responsive to MBNL1 dose. PLoS One (2012) 0.96
Analysis of exonic regions involved in nuclear localization, splicing activity, and dimerization of Muscleblind-like-1 isoforms. J Biol Chem (2011) 0.94
Progressive impairment of muscle regeneration in muscleblind-like 3 isoform knockout mice. Hum Mol Genet (2013) 0.92
Stochastic and reversible aggregation of mRNA with expanded CUG-triplet repeats. J Cell Sci (2011) 0.90
Nuclear localization of MBNL1: splicing-mediated autoregulation and repression of repeat-derived aberrant proteins. Hum Mol Genet (2014) 0.88
Combinatorial mutagenesis of MBNL1 zinc fingers elucidates distinct classes of regulatory events. Mol Cell Biol (2012) 0.87
DDX6 regulates sequestered nuclear CUG-expanded DMPK-mRNA in dystrophia myotonica type 1. Nucleic Acids Res (2014) 0.86
Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy. Nucleic Acids Res (2015) 0.86
Distal Alternative Last Exons Localize mRNAs to Neural Projections. Mol Cell (2016) 0.85
Tau exon 2 responsive elements deregulated in myotonic dystrophy type I are proximal to exon 2 and synergistically regulated by MBNL1 and MBNL2. Biochim Biophys Acta (2014) 0.83
Developmental insights into the pathology of and therapeutic strategies for DM1: Back to the basics. Dev Dyn (2015) 0.82
Molecular mechanisms in DM1 - a focus on foci. Nucleic Acids Res (2015) 0.81
Small molecule kinase inhibitors alleviate different molecular features of myotonic dystrophy type 1. RNA Biol (2014) 0.81